Genome-wide gene expression profiling to predict resistance to anthracyclines in breast cancer patients

Validated biomarkers predictive of response/resistance to anthracyclines in breast cancer are currently lacking. The neoadjuvant Trial of Principle (TOP) study, in which patients with estrogen receptor (ER)–negative tumors were treated with anthracycline (epirubicin) monotherapy, was specifically de...

全面介紹

Na minha lista:
書目詳細資料
發表在:Genom Data
Main Authors: Haibe-Kains, B., Desmedt, C., Di Leo, A., Azambuja, E., Larsimont, D., Selleslags, J., Delaloge, S., Duhem, C., Kains, J.P., Carly, B., Maerevoet, M., Vindevoghel, A., Rouas, G., Lallemand, F., Durbecq, V., Cardoso, F., Salgado, R., Rovere, R., Bontempi, G., Michiels, S., Buyse, M., Nogaret, J.M., Qi, Y., Symmans, F., Pusztai, L., D'Hondt, V., Piccart-Gebhart, M., Sotiriou, C.
格式: Artigo
語言:Inglês
出版: Elsevier 2013
主題:
Data in Brief
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC4608867/
https://ncbi.nlm.nih.gov/pubmed/26484051
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.gdata.2013.09.001
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍